CIK 0001635088 · Large accelerated filer
Roivant Sciences Ltd.
Sign in to watch- Ticker
- ROIV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- Bermuda
- Entity type
- operating
- EIN
- 981173944
- Phone
- 441-295-5950
- Business address
- 7TH FLOOR, 50 BROADWAY, LONDON, United Kingdom, SW1H 0DB
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $85,719,562
- in 13 filings, $45.5M under 10b5-1 plans
Net −$85,719,562. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-28 | Venker Eric President & Immunovant CEO | Sale 10b5-1 | −33,818 | $36.44 | $1.2M | 1,599,154 |
| 2026-08-28 | Venker Eric President & Immunovant CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −200,000 | 3,844,834 | ||
| 2026-08-21 | Sukhatme Mayukh President & CIO | Option exercise | +144,756 | $3.85 | $557K | 18,775,495 |
| 2026-08-21 | Sukhatme Mayukh President & CIO | Sale | −144,756 | $36.48 | $5.3M | 18,630,739 |
| 2026-08-21 | Sukhatme Mayukh President & CIO | Option exercise · Stock Option (Right to Buy) | −144,756 | 13,224,363 | ||
| 2026-08-20 | Pulik Richard CFO | Shares withheld for taxes | −5,749 | $36.84 | $212K | 271,810 |
| 2026-08-20 | Venker Eric President & Immunovant CEO | Shares withheld for taxes | −13,909 | $36.84 | $512K | 1,599,154 |
| 2026-08-20 | Sukhatme Mayukh President & CIO | Option exercise | +17,519 | $3.85 | $67K | 18,648,258 |
| 2026-08-20 | Sukhatme Mayukh President & CIO | Sale | −17,519 | $37.30 | $653K | 18,630,739 |
| 2026-08-20 | Sukhatme Mayukh President & CIO | Option exercise · Stock Option (Right to Buy) | −17,519 | 13,369,119 | ||
| 2026-08-19 | Sukhatme Mayukh President & CIO | Option exercise | +172,899 | $3.85 | $666K | 18,803,638 |
| 2026-08-19 | Sukhatme Mayukh President & CIO | Sale | −172,899 | $37.17 | $6.4M | 18,630,739 |
| 2026-08-19 | Sukhatme Mayukh President & CIO | Option exercise · Stock Option (Right to Buy) | −172,899 | 13,386,638 | ||
| 2026-08-18 | Sukhatme Mayukh President & CIO | Option exercise | +105,141 | $3.85 | $405K | 18,735,880 |
| 2026-08-18 | Sukhatme Mayukh President & CIO | Sale | −105,141 | $36.59 | $3.8M | 18,630,739 |
| 2026-08-18 | Sukhatme Mayukh President & CIO | Option exercise | +31,801 | $3.85 | $122K | 18,662,540 |
| 2026-08-18 | Sukhatme Mayukh President & CIO | Sale | −31,801 | $37.18 | $1.2M | 18,630,739 |
| 2026-08-18 | Sukhatme Mayukh President & CIO | Option exercise · Common Shares | −136,942 | 13,559,537 | ||
| 2026-08-17 | Sukhatme Mayukh President & CIO | Option exercise | +284,707 | $3.85 | $1.1M | 18,915,446 |
| 2026-08-17 | Sukhatme Mayukh President & CIO | Sale | −284,707 | $36.25 | $10.3M | 18,630,739 |
Page 5 of 29 · 570 trades